(Q44279397)

1 December 2017

Predictive value of serum thymidine kinase level for Ig-V mutational status in B-CLL. (English)

1 reference

1 December 2017

2

1 reference

1 December 2017

Magnac C

1

1 reference

1 December 2017

Davi F

3

1 reference

1 December 2017

Nataf J

4

1 reference

1 December 2017

Payelle-Brogard B

5

1 reference

1 December 2017

Tang RP

6

1 reference

1 December 2017

Oppezzo P

7

1 reference

1 December 2017

Lévy V

8

1 reference

1 December 2017

Dighiero G

9

1 reference

1 December 2017

Ajchenbaum-Cymbalista F

10

1 reference

1 December 2017

1 January 2003

1 reference

1 December 2017

1 reference

1 December 2017

17

1 reference

1 December 2017

1

1 reference

1 December 2017

133-137

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.leu.2402780

1 December 2017

0 references

cites work

The pathogenesis of chronic lymphocytic leukemia: analysis of the antibody repertoire

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402780

Chronic lymphocytic leukemia B cells express restricted sets of mutated and unmutated antigen receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402780

Retrospective study of the prognostic role of serum thymidine kinase level in CLL patients with active disease treated with fludarabine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402780

VH gene usage by family members affected with chronic lymphocytic leukaemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402780

Increased expression of cyclin D2 during multiple states of growth arrest in primary and established cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402780

Chlorambucil in indolent chronic lymphocytic leukemia. French Cooperative Group on Chronic Lymphocytic Leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402780

Randomized comparison of fludarabine, CAP, and ChOP in 938 previously untreated stage B and C chronic lymphocytic leukemia patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402780

Influence of unrecognized molecular heterogeneity on randomized clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402780

Relation of gene expression phenotype to immunoglobulin mutation genotype in B cell chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402780

Gene expression profiling of B cell chronic lymphocytic leukemia reveals a homogeneous phenotype related to memory B cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402780

Cyclin D2 is essential for BCR-mediated proliferation and CD5 B cell development

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402780

CD38 expression and Ig VH gene mutation in B-cell chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402780

inferred from DOI database lookup

7 January 2021

based on heuristic

CD38 expression is a poor predictor for VH gene mutational status and prognosis in chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402780

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/SJ.LEU.2402780

1 reference

Dimensions Publication ID

1 December 2017

0 references

1 reference